Kurata Kentaro, Hosono Katsuhiro, Hotta Yoshihiro
Department of Ophthalmology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Case Rep Ophthalmol. 2017 Apr 10;8(1):237-244. doi: 10.1159/000462961. eCollection 2017 Jan-Apr.
This report describes a 45-year-old man with complete congenital stationary night blindness (CSNB1) who has been followed up for 38 years.
The patient first visited our hospital as a 7-year-old boy with a complaint of low visual acuity. Best corrected visual acuity (BCVA) was 0.5 in the right eye and 0.6 in the left eye. The refractive error was approximately -5.0 D in both eyes. The fundus showed only myopic changes. A bright-flash electroretinogram (ERG) revealed a negative configuration. We diagnosed CSNB and corrected the refractive error with glasses. We continued to monitor the ERG and various waveform components as well as visual acuity and the appearance of the fundus. All exons were screened for a causative mutation by polymerase chain reaction amplification, and direct sequencing was performed.
By 10 years of age, BCVA had increased to 0.8 on the right and 0.9 on the left, with little change thereafter. The fundus continued to show only myopic changes. No changes were seen in the amplitude or implicit time of the a-wave or b-wave or in the b/a-wave ratio. A novel hemizygous insertion mutation, c.1205_1206insT, p.(Glu404Argfs*89), was detected in exon 2 of the gene.
To our knowledge, this is the longest follow-up of a patient with CSNB1. No changes in the clinical course have been seen during follow-up. We believe that it is important to continue observations and accumulate clinical data for prognostic purposes on patients with CSNB1.
本报告描述了一名患有完全性先天性静止性夜盲症(CSNB1)的45岁男性,其随访时间长达38年。
该患者7岁时因视力低下首次就诊于我院。最佳矫正视力(BCVA)右眼为0.5,左眼为0.6。双眼屈光不正约为-5.0D。眼底仅显示近视性改变。闪光视网膜电图(ERG)显示为负相。我们诊断为CSNB,并配镜矫正屈光不正。我们持续监测ERG及其各种波形成分、视力和眼底外观。通过聚合酶链反应扩增对所有外显子进行致病突变筛查,并进行直接测序。
到10岁时,BCVA右眼提高到0.8,左眼提高到0.9,此后变化不大。眼底继续仅显示近视性改变。a波或b波的振幅、隐含时间或b/a波比值均未见变化。在该基因的第2外显子中检测到一个新的半合子插入突变,c.1205_1206insT,p.(Glu404Argfs*89)。
据我们所知,这是对一名CSNB1患者最长时间的随访。随访期间临床病程未见变化。我们认为,持续观察并积累CSNB1患者的临床数据对于预后评估很重要。